BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18824873)

  • 1. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
    Bolcic F; Bull L; Martinez L; Reynoso R; Salomon H; Arduino R; Barnett B; Quarleri J
    Intervirology; 2008; 51(4):261-4. PubMed ID: 18824873
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy.
    Hofmann WP; Zeuzem S; Sarrazin C
    J Clin Virol; 2005 Feb; 32(2):86-91. PubMed ID: 15653410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV/HIV co-infection therapy.
    Pietrandoni G
    Posit Aware; 2002; 13(2):32, 38. PubMed ID: 12004829
    [No Abstract]   [Full Text] [Related]  

  • 5. Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.
    Taylor LE; Schwartzapfel B; Allen S; Jacobs G; Mitty J
    Clin Infect Dis; 2003 Jun; 36(11):1501-2; author reply 1502-3. PubMed ID: 12766851
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma interferon-gamma-inducible protein-10 can predict virologic response to hepatitis C virus therapy in HIV/HCV-coinfected patients with HCV genotype 1.
    Vargas A; Berenguer J; Ryan P; Catalán P; López JC; Cosín J; Miralles P; Resino S
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):219-20. PubMed ID: 20505475
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C virus--structure, replication and therapeutical opportunities and the phenomenon of resistance].
    Kowala-Piaskowska A
    Postepy Biochem; 2006; 52(4):399-407. PubMed ID: 17536509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
    Torres-Puente M; Cuevas JM; Jiménez-Hernández N; Bracho MA; García-Robles I; Carnicer F; del Olmo J; Ortega E; Moya A; González-Candelas F
    J Med Virol; 2008 Feb; 80(2):247-53. PubMed ID: 18098147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV quasispecies evolution during treatment with interferon alfa-2b and ribavirin in two children coinfected with HCV and HIV-1.
    Quesnel-Vallières M; Lemay M; Lapointe N; Martin SR; Soudeyns H
    J Clin Virol; 2008 Oct; 43(2):236-40. PubMed ID: 18707918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of the HCV/HIV-coinfected patient.
    Sherman KE
    AIDS Clin Care; 2002 May; 14(5):39-43, 48. PubMed ID: 12004876
    [No Abstract]   [Full Text] [Related]  

  • 12. Physician do no harm.
    Cameron S
    Antivir Ther; 2012; 17(6):1101. PubMed ID: 22647550
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy.
    Landau A; Batisse D; Piketty C; Jian R; Kazatchkine MD
    AIDS; 2000 Aug; 14(12):1857-8. PubMed ID: 10985327
    [No Abstract]   [Full Text] [Related]  

  • 14. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
    Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
    J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and HIV: ribavirin plus interferon study recruiting.
    AIDS Treat News; 1998 May; (No 295):5. PubMed ID: 11365407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating hepatitis C virus in HIV patients: are side effects a real obstacle?
    Gatti F; Nasta P; Matti A; Manno D; Mendeni M; Puoti M; Carosi G
    AIDS Rev; 2007; 9(1):16-24. PubMed ID: 17474310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno R; Fagiuoli S; Sacchi P
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):699-701. PubMed ID: 21905777
    [No Abstract]   [Full Text] [Related]  

  • 18. When HIV and HCV cohabitate.
    Cohen AJ
    GMHC Treat Issues; 1999 Apr; 13(4):5-7, 10. PubMed ID: 11366977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible compartmentalization of hepatitis C viral replication in the genital tract of HIV-1-coinfected women.
    Minosse C; Calcaterra S; Abbate I; Selleri M; Zaniratti MS; Capobianchi MR
    J Infect Dis; 2006 Dec; 194(11):1529-36. PubMed ID: 17083037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia.
    Bruchfeld A; Lindahl K; Stahle L; Schvarcz R
    J Hepatol; 2006 Feb; 44(2):432-3; author reply 433. PubMed ID: 16338023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.